{"id":382199,"date":"2020-11-16T16:08:27","date_gmt":"2020-11-16T21:08:27","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=382199"},"modified":"2020-11-16T16:08:27","modified_gmt":"2020-11-16T21:08:27","slug":"qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/","title":{"rendered":"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>Fast and easy-to-use respiratory PCR test comes onto market as flu season gains pace in Northern Hemisphere<\/i><\/li>\n<li><i>CE-IVD marking in Europe granted for NeuMoDx\u2122 Flu A-B\/RSV\/SARS-CoV-2 Vantage Test, has also been submitted to FDA for Emergency Use Authorization<\/i><\/li>\n<li><i>Test adds to QIAGEN\u2019s growing portfolio of PCR testing solutions for COVID-19 testing <\/i><\/li>\n<li><i>QIAGEN also expands sample type claim for NeuMoDx\u2122 SARS-CoV-2 test to include saliva from a dedicated collection kit in Europe<\/i><\/li>\n<\/ul>\n<p>GERMANTOWN, Md. &amp; HILDEN, Germany&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nQIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the <i>NeuMoDx\u2122 Flu A-B\/RSV\/SARS-CoV-2 Vantage<\/i><i>Test<\/i> that will help healthcare professionals quickly identify and differentiate between patients with common seasonal respiratory infections and COVID-19.\n<\/p>\n<p>\nWith the Northern Hemisphere in the grip of flu season, this multiplex polymerase chain reaction (PCR) test detects and differentiates influenzas A and B, respiratory syncytial virus (RSV) and SARS-CoV-2 infections within 80 minutes. These viruses produce similar respiratory symptoms, making it essential to provide differential diagnosis among them for patient treatment and management decisions, especially in the COVID-19 pandemic.\n<\/p>\n<p>\nQIAGEN has launched <i>NeuMoDx\u2122 Flu A-B\/RSV\/SARS-CoV-2 Vantage <\/i>in the European Union and other markets after CE-IVD registration, and has submitted an Emergency Use Authorization (EUA) request to the FDA.\n<\/p>\n<p>\nQIAGEN\u2019s new respiratory test takes advantage of the NeuMoDx 96 and NeuMoDx 288 molecular systems\u2019 automated three-step workflow. Coupled with additional system features \u00ad\u00ad\u2013 like processing capacity, true random access, and continuous loading of samples, reagents and consumables while the system is running \u2013 the <i>NeuMoDx\u2122 Flu A-B\/RSV\/SARS-CoV-2 Vantage<\/i> test will be a powerful diagnostic tool for the flu season and COVID-19 pandemic.\n<\/p>\n<p>\nIn addition, QIAGEN has expanded specimen types that can be used on the existing <i>NeuMoDx\u2122 SARS-CoV-2<\/i> test. CE-IVD approval has been obtained for the use of saliva samples collected with the <i>NeuMoDx\u2122 Saliva Collection Kit<\/i>, which includes a collection vial, stabilization tube and pipette.\n<\/p>\n<p>\nPlease find the full press release <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcorporate.qiagen.com%2Fnewsroom%2Fpress-releases%2F2020%2F20201116_neumodx_ce_multiplex%3Fsc_lang%3Dde-DE&amp;esheet=52328667&amp;newsitemid=20201116005870&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=c3928dd99fe6bddcb1e8085397914366\">here<\/a><\/p>\n<p class=\"bwalignc\">\n###\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201116005870r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201116005870\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201116005870\/en\/<\/a><\/span><\/p>\n<p><b>Investor Relations<br \/>\n<\/b><br \/>John Gilardi<br \/>\n<br \/>+49 2103 29 11711<br \/>\n<br \/>Phoebe Loh<br \/>\n<br \/>+49 2103 29 11457<br \/>\n<br \/>e-mail: <a rel=\"nofollow\" href=\"mailto:ir@QIAGEN.com\">ir@QIAGEN.com<\/a><\/p>\n<p><b>Public Relations<br \/>\n<\/b><br \/>Thomas Theuringer<br \/>\n<br \/>+49 2103 29 11826<br \/>\n<br \/>Robert Reitze<br \/>\n<br \/>+49 2103 29 11676<br \/>\n<br \/>e-mail: <a rel=\"nofollow\" href=\"mailto:pr@QIAGEN.com\">pr@QIAGEN.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Switzerland United States Austria North America Europe Germany Maryland<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Medical Devices Infectious Diseases Technology Other Technology Research Science<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets Fast and easy-to-use respiratory PCR test comes onto market as flu season gains pace in Northern Hemisphere CE-IVD marking in Europe granted for NeuMoDx\u2122 Flu A-B\/RSV\/SARS-CoV-2 Vantage Test, has also been submitted to FDA for Emergency Use Authorization Test adds to QIAGEN\u2019s growing portfolio of PCR testing solutions for COVID-19 testing QIAGEN also expands sample type claim for NeuMoDx\u2122 SARS-CoV-2 test to include saliva from a dedicated collection kit in Europe GERMANTOWN, Md. &amp; HILDEN, Germany&#8211;(BUSINESS WIRE)&#8211; QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx\u2122 Flu A-B\/RSV\/SARS-CoV-2 VantageTest that will help healthcare professionals quickly identify &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-382199","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets Fast and easy-to-use respiratory PCR test comes onto market as flu season gains pace in Northern Hemisphere CE-IVD marking in Europe granted for NeuMoDx\u2122 Flu A-B\/RSV\/SARS-CoV-2 Vantage Test, has also been submitted to FDA for Emergency Use Authorization Test adds to QIAGEN\u2019s growing portfolio of PCR testing solutions for COVID-19 testing QIAGEN also expands sample type claim for NeuMoDx\u2122 SARS-CoV-2 test to include saliva from a dedicated collection kit in Europe GERMANTOWN, Md. &amp; HILDEN, Germany&#8211;(BUSINESS WIRE)&#8211; QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx\u2122 Flu A-B\/RSV\/SARS-CoV-2 VantageTest that will help healthcare professionals quickly identify &hellip; Continue reading &quot;QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-16T21:08:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201116005870r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets\",\"datePublished\":\"2020-11-16T21:08:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/\"},\"wordCount\":416,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201116005870r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/\",\"name\":\"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201116005870r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-11-16T21:08:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201116005870r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201116005870r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/","og_locale":"en_US","og_type":"article","og_title":"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets - Market Newsdesk","og_description":"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets Fast and easy-to-use respiratory PCR test comes onto market as flu season gains pace in Northern Hemisphere CE-IVD marking in Europe granted for NeuMoDx\u2122 Flu A-B\/RSV\/SARS-CoV-2 Vantage Test, has also been submitted to FDA for Emergency Use Authorization Test adds to QIAGEN\u2019s growing portfolio of PCR testing solutions for COVID-19 testing QIAGEN also expands sample type claim for NeuMoDx\u2122 SARS-CoV-2 test to include saliva from a dedicated collection kit in Europe GERMANTOWN, Md. &amp; HILDEN, Germany&#8211;(BUSINESS WIRE)&#8211; QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx\u2122 Flu A-B\/RSV\/SARS-CoV-2 VantageTest that will help healthcare professionals quickly identify &hellip; Continue reading \"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-16T21:08:27+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201116005870r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets","datePublished":"2020-11-16T21:08:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/"},"wordCount":416,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201116005870r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/","name":"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201116005870r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-11-16T21:08:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201116005870r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201116005870r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-neumodx-multiplex-test-to-complete-range-of-sars-cov-2-testing-solutions-in-europe-and-other-markets\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=382199"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382199\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=382199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=382199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=382199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}